Trading resumes in: Company: Cresco Labs Inc. CSE Symbol: CL All Issues: No Resumption (ET): 10:02:47 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which […]
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Capricor To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Capricor between October 9, 2024 and July 10, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi
The following issues have been halted by CIRO: Company: Cresco Labs Inc. CSE Symbol: CL All Issues: No Reason: Single Stock Circuit Breaker Halt Time (ET): 9:57:47 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a
WICHITA, Kan., Aug. 29, 2025 (GLOBE NEWSWIRE) — Legend Senior Living(R), a nationally recognized senior living provider headquartered in Wichita, KS, has announced the addition of two new residences to its growing portfolio, including its first location in Missouri. The company has assumed management of newly named The Vero of O'Fallon, located in St. Charles,
Legend Senior Living(R) Acquires Two New Residences, Expands Into Missouri GlobeNewswire August 29, 2025 WICHITA, Kan., Aug. 29, 2025 (GLOBE NEWSWIRE) — Legend Senior Living(R), a nationally recognized senior living provider headquartered in Wichita, KS, has announced the addition of two new residences to its growing portfolio, including its first location in Missouri. The company
(NASDAQ:NEO), NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether NeoGenomics and certain of its officers and/or directors have engaged
(NASDAQ:ANIK), NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Anika Therapeutics, Inc. (“Anika” or the “Company”) (NASDAQ: ANIK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Anika and certain of its officers and/or directors have
(NasdaqGM:PRAX), NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Praxis Precision Medicines, Inc. (“Praxis” or the “Company”) (NASDAQ: PRAX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Praxis and certain of its officers and/or directors
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. – NEO GlobeNewswire August 29, 2025 NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO). Such investors are advised to contact Danielle Peyton at
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Praxis Precision Medicines, Inc. – PRAX GlobeNewswire August 29, 2025 NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Praxis Precision Medicines, Inc. (“Praxis” or the “Company”) (NASDAQ: PRAX). Such investors are advised to